Abstract:The amyloid-beta precursor protein (APP) and its pathogenic byproduct beta-amyloid peptide (A beta) play central roles in the pathogenesis of Alzheimer's disease (AD). Reduction in levels of the potentially toxic A beta is one of the most important therapeutic goals in AD. Recent studies have shown that bivalent metals such as iron, copper, and zinc are involved in APP expression, A beta deposition, and senile plaque formation in the AD brain. However, the underlying mechanisms involved in abnormal homeostasis of bivalent metals in AD brain remain unclear. In the present study, we found that two isoforms of the divalent metal transporter 1 (DMT1), DMT1-IRE, and DMT1-nonIRE, were colocalized with A beta in the plaques of postmortem AD brain. Using the APP/PS1 transgenic mouse model, we found that the levels of both DMT1-IRE and DMT1-nonIRE were significantly increased in the cortex and hippocampus compared with wild type-control. We further verified the proposed mechanisms by which DMT1 might be involved in APP processing and A beta secretion by using the SH-SY5Y cell line stably overexpressing human APP Swedish mutation (APPsw) as a cell model. We found that overexpression of APPsw resulted in increased expression levels of both DMT1-IRE and DMT1-nonIRE in SH-SY5Y cells. Interestingly, silencing of endogenous DMT1 by RNA interference, which reduced bivalent ion influx, led to reductions of APP expression and A beta secretion. These findings suggest both that DMT1 plays a critical role in ion-mediated neuropathogenesis in AD and that pharmacological blockage of DMT1 may provide novel therapeutic strategies against AD.-Zheng, W., Xin, N., Chi, Z.-H., Zhao, B.-L., Zhang, J., Li, J.-Y., Wang, Z.-Y. Divalent metal transporter 1 (DMT1) is involved in amyloid precursor protein processing and A beta generation. FASEB J. 23, 4207-4217 (2009). www.fasebj.org

Upregulation of Divalent Metal Transporter 1 (DMT1) is Involved in Amyloid Precursor Protein Processing and Aβ Generation

Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation.

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

The Release and Transmission of Amyloid Precursor Protein Via Exosomes

Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity.

Amyolid Precursor Protein Mediates Presynaptic Localization and Activity of the High-Affinity Choline Transporter

Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Aβ-mediated neurotoxicity: Microglia-mediated oxidative neurotoxicity

Activation Of Mitochondrial Unfolded Protein Response In Shsy5y Expressing App Cells And App/Ps1 Mice

Localization of DMT1 in Cerebral Cortes of APP/PS1 Transgenic Mouse Brain

The roles of amyloid precursor protein (APP) in neurogenesis: Implications to pathogenesis and therapy of Alzheimer disease.

Interaction Between Amyloid Precursor Protein and Nogo Receptors Regulates Amyloid Deposition

Proteolytic processing of Alzheimer's β-amyloid precursor protein.

The Role of Copper and the Copper-Related Protein CUTA in Mediating APP Processing and Aβ Generation

Modifications and Trafficking of APP in the Pathogenesis of Alzheimer's Disease

The amyloid precursor protein: beyond amyloid

Modifications and Trafficking of APP in the Pathogenesis of Alzheimer’s Disease

Advances in the β-amyloid precursor protein of Alzheimer's disease

Molecular and cellular mechanisms for Alzheimer's disease: understanding APP metabolism.

Novel upregulation of amyloid-β precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5′-untranslated region: Implications in Alzheimer’s disease

Secretases Related to Amyloid Precursor Protein Processing

β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease.